Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Launchcyte
AddedFeb 15, 2024
UpdatedJun 28, 2026
Launchcyte

Launchcyte

LaunchCyte, founded in 2000, forms life sciences companies to commercialize innovative healthcare technologies.

HQ
Pittsburgh, PA, US
Founded
2000
Overview
Compare
Fundraising
Employees
Website

LaunchCyte, founded in 2000, is dedicated to creating life sciences companies that commercialize innovative healthcare technologies. The company identifies promising technologies from leading research universities and forms businesses to bring these innovations to market. LaunchCyte's portfolio includes five companies—Celsense, Crystalplex, Immunetrics, Knopp Biosciences, and Reaction Biology—offering solutions in healthcare, lighting, and display industries.

Notable affiliated individuals include experts from various scientific and business fields who contribute to the success of each portfolio company. LaunchCyte has garnered investments from both private and institutional investors, reflecting confidence in its mission and vision. Key achievements include the successful commercialization of groundbreaking technologies that improve healthcare outcomes. Overall, LaunchCyte has made a significant impact by translating academic research into practical applications that benefit society.

Launchcyte - Similar Companies

LifeX logo

LifeX

lifex-labs.com

Accelerator Life Science Partners logo

Accelerator Life Science Partners

acceleratorlsp.com

RareCyte logo

RareCyte

rarecyte.com

RhinoCyte logo

RhinoCyte

rhinocyte.com

LumaCyte logo

LumaCyte

lumacyte.com

CyOmics logo

CyOmics

EyeCyte logo

EyeCyte

eyecyte.com

Biotechonomy logo

Biotechonomy

Virogenomics logo

Virogenomics

virogenomics.com

Agile Sciences logo

Agile Sciences

agilesci.com

Techcyte logo

Techcyte

techcyte.com

Bioventure Partners logo

Bioventure Partners

Transomic Technologies logo

Transomic Technologies

BioAccel logo

BioAccel

jCyte logo

jCyte

jcyte.com

Launchcyte - Quick Facts

Who are Launchcyte's competitors?

Companies similar to Launchcyte include LifeX, Accelerator Life Science Partners, RareCyte and RhinoCyte.

When was Launchcyte founded?

Launchcyte was founded in 2000.

Where is Launchcyte's headquarters located?

Launchcyte's headquarters is located in Pittsburgh, PA, US.

When was Launchcyte's last funding round?

Launchcyte's most recent funding round was for $1.1M (USD) in May 2011.

How much has Launchcyte raised to-date?

As of May 19, 2011, Launchcyte has raised a total of $3.3M (USD).

How many employees does Launchcyte have?

Launchcyte has 2 employees as of Feb 5, 2024.

Launchcyte - Classification

Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Customer
  • Enterprise
Main Product
  • Biotech
  • Healthcare
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 5 more industry codes
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified